M K Kalaivani, John Cordelia Mano, Jonnagaladda Bhavana, Kesavan Akila, Arockiasamy Sumathy
Department of Biomedical Sciences, Sri Ramachandra Institute of Higher Education and Research (DU), Porur, Chennai 6000116, India.
Department of Human Genetics, Sri Ramachandra Institute of Higher Education and Research (DU), Porur, Chennai, 600116, India.
Iran J Basic Med Sci. 2021 Aug;24(8):1087-1097. doi: 10.22038/ijbms.2021.56519.12618.
The protective effect of ethyl acetate fraction (EAF) of roots against Tacrolimus (TAC) induced nephrotoxicity was studied using MDCK cell lines.
Ethanolic root extract of was fractionated using the liquid-liquid partition method. The cytotoxic effect of TAC and protective effect of EAF co-treatment were studied in MDCK cell lines by measuring ROS, LPO, and NO levels; collagen accumulation, effect on mitochondrial membrane integrity and cell cycle analysis were studied. The active component in EAF was quantified by HPLC analysis.
TAC induced toxicity, leading to apoptosis and necrosis, was significantly reduced (<0.001) in EAF co-treatment, with reversal of cell cycle arrest and reduced cell population at sub G0/G1 phase. Further, ROS (<0.05), LPO and NO (<0.001), were significantly reduced with EAF co-treatment compared with TAC individually treated cells. TAC induced mitochondrial membrane integrity loss was found to be significantly reduced in co-treated cells, as measured by rhodamine123 (<0.05) and translocation of cytochrome c (<0.001) from nucleus to cytoplasm, and caspase 3 release (<0.001). The same was confirmed through annexin-FITC and PI staining (<0.05) with reduced apoptotic and necrotic death in co-treated population. Interestingly, EAF co-treatment decreased collagen accumulation (<0.001) with significant increase in the cell survival of tubular epithelial cells. HPLC analysis showed the presence of Quercetin (87.5 mg/g) in EAF, which may be responsible for the nephroprotective role.
Thus, these results provide sound evidence that EAF may be an effective adjuvant therapy to prevent nephrotoxicity induced by TAC.
使用MDCK细胞系研究根部乙酸乙酯部位(EAF)对他克莫司(TAC)诱导的肾毒性的保护作用。
采用液-液分配法对根部乙醇提取物进行分离。通过测量活性氧(ROS)、脂质过氧化(LPO)和一氧化氮(NO)水平,研究TAC的细胞毒性作用以及EAF联合处理的保护作用;研究胶原积累、对线粒体膜完整性的影响以及细胞周期分析。通过高效液相色谱(HPLC)分析对EAF中的活性成分进行定量。
在EAF联合处理组中,TAC诱导的导致凋亡和坏死的毒性显著降低(<0.001),细胞周期阻滞得到逆转,亚G0/G1期细胞数量减少。此外,与单独用TAC处理的细胞相比,EAF联合处理组的ROS(<0.05)、LPO和NO(<0.001)显著降低。通过罗丹明123(<0.05)以及细胞色素c从细胞核向细胞质的转位(<0.001)和半胱天冬酶3的释放(<0.001)测量发现,TAC诱导的联合处理细胞中线粒体膜完整性丧失显著降低。通过膜联蛋白-FITC和碘化丙啶染色(<0.05)证实了这一点,联合处理组中凋亡和坏死性死亡减少。有趣的是,EAF联合处理减少了胶原积累(<0.001),同时肾小管上皮细胞的细胞存活率显著增加。HPLC分析表明EAF中存在槲皮素(87.5 mg/g),这可能是其发挥肾保护作用的原因。
因此,这些结果提供了充分的证据表明EAF可能是预防TAC诱导的肾毒性的有效辅助治疗方法。